A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice | Scientific Reports - Nature.com
Scientific Reports - A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice
Materials
Imiquimod with 99% purity, ethanol, and TWEEN-80, were acquired from Sigma Aldrich (Germany). Phospholipon 90G (PL90G) was gifted by Lipoid GmbH (Ludwigshafen, Germany). Imiquimod 5% marke… [+18102 chars]
Read More
Other Stories in Business
- RIL shares in focus as Bernstein, Jefferies turn bullish after recent fall, see up to 36% upside
- Amazon Set To Benefit From Mexico's Import Tariffs Affecting Temu, Shein — Analysts See Window Of Opportunity For Established Players - MercadoLibre (NASDAQ:MELI), Amazon.com (NASDAQ:AMZN)
- Nvidia Is Looking Good For The 2025 Calendar Year (NVDA)
- Bill Gates' net worth: How Microsoft's co-founder spends his $160 billion, including properties, cars, and philanthropy
- - ????? ???? ????? ????? ???? ??? ????? ???? ??????
- ????? ?? ??????
- Medium's payout algorithm is somewhat opaque, but here are the key points we know about how it functions:
- Super Micro Computer: Warning Signals Should Make This A Straightforward Sell
- Kalpataru Projects shares in focus today on fresh order win, check details
